Raw data for: Structure-Based Repurposing of FDA-Approved drugs Reveals Dual MAPK and PPG Inhibitors in Leishmania donovani

20260 citationsJournal Articlegreen Open Access

Authors

Abstract

This file contains the raw data for: Structure-Based Repurposing of FDA-Approved drugs Reveals Dual MAPK and PPG Inhibitors in Leishmania donovani. The zip file also contains a readme file for reference.

Topics & Keywords

Research on Leishmaniasis Studies Macrophage Migration Inhibitory Factor Trypanosoma species research and implications

Publication Details

Published in: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.18204763

Field-Weighted Citation Impact: 0.00

Command Palette

Raw data for: Structure-Based Repurposing of FDA-Approved drugs Reveals Dual MAPK and PPG Inhibitors in Leishmania donovani

Authors

Abstract

Topics & Keywords

Publication Details